The U.S. Army Medical Research and Development Command recently awarded MLM Biologics, Inc. almost $1.5 million to develop a device to prevent infection in battlefield wounds.
The U.S. Army Medical Research and Development Command recently awarded MLM Biologics, Inc. almost $1.5 million to develop a device to prevent infection in battlefield wounds.